<?xml version="1.0" encoding="UTF-8"?>
<p id="p0555">Preparations need to be made now in order to ensure that emergency vaccine use in accompanied with robust vaccine safety surveillance and a process for safety assessment which will maintain public confidence in the vaccine. The vaccine will likely be used with COVID-19 widely circulating. Thus safety surveillance will need to distinguish between health outcomes caused by the disease versus those caused by the vaccine. Real or coincidental AESIs and AEFIs have the potential to undermine the vaccine program and exacerbate public fear around the pandemic.</p>
